About
CEVR Team
Careers
Read for the Registry
Contact Us
News & Events
News
Events
Publications
Projects
Databases
CEA Registry
GH CEA Registry
SPEC Database
Sponsorship
Sponsor login
Contact Us
News & Events
News
The Tufts-CEVR HEOR Leaders Survey: How worried should HEOR be about its future?
How worried should HEOR be about its future? A survey of US pharma HEOR leaders Peter J. Neumann, ScD,a Grace Hatfield, BA,a Tom Hughes, BScPharm,b ...
US commercial health plan use of corticosteroids in step therapy protocols: Frequency and clinical appropriateness
Abstract BACKGROUND: Commercial health plans may include corticosteroids in step therapy protocols for specialty drugs as part of use management. Howe...
340B’s Reckoning: The Price Behind the Discount
June 24, 2026 Brian Reid and Peter J. Neumann Much of the attention around the 340B drug discount program highlights the limited evidence that eligibl...
View All News Items
Events
CEVR Health Policy Seminar with Julia F. Slejko PhD
CEVR Health Policy Seminar with Melanie Calvert, PhD, FMedSci
2026 CEVR Annual Meeting
View All Events
Publications
Journal of Managed Care & Specialty Pharmacy
US commercial health plan use of corticosteroids in step therapy protocols: Frequency and clinical appropriateness
Health Affairs Forefront
Lessons From TAVR For Medicare’s ‘Coverage With Evidence Development’ Program
Learning Health Systems
Effect of Using Personalized Estimates of Diabetes Risk During Primary Care Visits for People With Prediabetes
JCO Oncology Practice
Trends in Utilization Management for Oncology Therapies Amongst US Commercial Health Plans: 2017-2024
ISPOR 2026 (Poster Presentation)
Variation in Commercial Health Plan Coverage of Atopic Dermatitis Therapies
ISPOR 2026 (Poster Presentation)
Alignment of Health Plan Reauthorization Criteria with Clinical Trial Endpoints for Neuromuscular Disease Therapies
ISPOR 2026 (Poster Presentation)
FDA Approvals of Specialty Drugs, 2000-2024
ISPOR 2026 (Poster Presentation)
A Survey of HEOR Leaders in Pharma on the Changing US Policy Landscape
ISPOR 2026 (Poster Presentation)
The Unintended Consequences of the Inflation Reduction Act on Biosimilar Market Incentives and Medicare Savings
View All Publications
